ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.47B
Enterprise Value 31.11B
Trailing P/E 21.78
Forward P/E 1-59.68
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.12
Price/Book (mrq)3.73
Enterprise Value/Revenue 35.36
Enterprise Value/EBITDA 612.19

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2018
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 34.82%
Operating Margin (ttm)42.75%

Management Effectiveness

Return on Assets (ttm)14.90%
Return on Equity (ttm)20.67%

Income Statement

Revenue (ttm)206.62M
Revenue Per Share (ttm)10.73
Quarterly Revenue Growth (yoy)-11.50%
Gross Profit (ttm)206.62M
EBITDA 90.85M
Net Income Avi to Common (ttm)71.96M
Diluted EPS (ttm)3.48
Quarterly Earnings Growth (yoy)-24.90%

Balance Sheet

Total Cash (mrq)308.73M
Total Cash Per Share (mrq)15.89
Total Debt (mrq)1.92M
Total Debt/Equity (mrq)0.49
Current Ratio (mrq)23.74
Book Value Per Share (mrq)20.30

Cash Flow Statement

Operating Cash Flow (ttm)29.22M
Levered Free Cash Flow (ttm)8.12M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.72
52-Week Change 310.70%
S&P500 52-Week Change 3-7.85%
52 Week High 3127.77
52 Week Low 361.39
50-Day Moving Average 373.96
200-Day Moving Average 387.63

Share Statistics

Avg Vol (3 month) 3259.72k
Avg Vol (10 day) 3238.1k
Shares Outstanding 519.42M
Float 14.83M
% Held by Insiders 123.83%
% Held by Institutions 185.72%
Shares Short (Dec 31, 2018) 42.76M
Short Ratio (Dec 31, 2018) 49.4
Short % of Float (Dec 31, 2018) 4N/A
Short % of Shares Outstanding (Dec 31, 2018) 414.21%
Shares Short (prior month Nov 30, 2018) 42.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A